CalciMedica, Inc. is a biotech company focused on developing innovative therapies for the treatment of serious and debilitating diseases, particularly those related to calcium signaling pathways. The company specializes in leveraging its proprietary platform to design small molecule drugs that target specific ion channels involved in various pathological conditions. Through its research and development efforts, CalciMedica aims to address unmet medical needs and improve patient outcomes in disease areas such as autoimmune disorders and other inflammatory conditions. Their commitment to advancing scientific knowledge and drug development reflects their goal of transforming patient care through effective treatment options. Read More
The Dow Jones index closed lower by around 400 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
As of Feb. 2, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The Dow Jones closed higher by around 35 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.
International expansion of CARPO, a Phase 2b clinical trial of Auxora in acute pancreatitis (AP) patients with accompanying systemic inflammatory response syndrome (SIRS), in India
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) shares jumped 105% to $0.2050 after the company signed a distribution agreement with Cardinal Health.
